Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (202)
Taysha Gene Therapies, Inc. (TSHA)
Nagendran Sukumar — Director
Shares
200,000
Price
$6.24
Total Value
$1.25M
Shares Held After
936,410
% of Holdings
17.6%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,000
Price
$0.94
Total Value
$940.00
Shares Held After
369,485
% of Holdings
0.3%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
229
Price
$73.95
Total Value
$16.93K
Shares Held After
492,241
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
325
Price
$550.59
Total Value
$178.94K
Shares Held After
450
% of Holdings
41.9%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
2,171
Price
$30.30
Total Value
$65.78K
Shares Held After
57,733
% of Holdings
3.6%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
25,000
Price
$1.96
Total Value
$48.90K
Shares Held After
461,904
% of Holdings
5.4%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,000
Price
$0.90
Total Value
$900.00
Shares Held After
368,485
% of Holdings
0.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
25
Price
$16.00
Total Value
$400.00
Shares Held After
135,202
% of Holdings
0.0%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
536
Price
$29.00
Total Value
$15.54K
Shares Held After
181,641
% of Holdings
0.3%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
2,111
Price
$123.81
Total Value
$261.36K
Shares Held After
63,493
% of Holdings
3.2%
INSMED Inc (INSM)
Lewis William — Director
Shares
3,359
Price
$118.52
Total Value
$398.11K
Shares Held After
259,058
% of Holdings
1.3%
INSMED Inc (INSM)
Lewis William — Director
Shares
2,335
Price
$117.62
Total Value
$274.64K
Shares Held After
262,417
% of Holdings
0.9%
INSMED Inc (INSM)
Lewis William — Director
Shares
5,005
Price
$116.55
Total Value
$583.33K
Shares Held After
264,752
% of Holdings
1.9%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
10,000
Price
$40.00
Total Value
$400.00K
Shares Held After
119,763
% of Holdings
7.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$555.76
Total Value
$66.69K
Shares Held After
40,513
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$554.23
Total Value
$354.70K
Shares Held After
40,633
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
801
Price
$553.29
Total Value
$443.19K
Shares Held After
41,273
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,648
Price
$552.38
Total Value
$910.32K
Shares Held After
42,074
% of Holdings
3.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,863
Price
$551.03
Total Value
$1.58M
Shares Held After
43,722
% of Holdings
6.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,452
Price
$550.12
Total Value
$798.78K
Shares Held After
46,585
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,536
Price
$549.01
Total Value
$843.27K
Shares Held After
48,037
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$548.16
Total Value
$241.19K
Shares Held After
49,573
% of Holdings
0.9%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
12,606
Price
$6.96
Total Value
$87.78K
Shares Held After
290,623
% of Holdings
4.2%
ABEONA THERAPEUTICS INC. (ABEO)
Seshadri Vishwas — Director
Shares
67,971
Price
$6.96
Total Value
$473.33K
Shares Held After
1,306,108
% of Holdings
4.9%
ABEONA THERAPEUTICS INC. (ABEO)
O'Malley Brendan M. — SVP, Chief Legal Officer
Shares
12,050
Price
$6.96
Total Value
$83.91K
Shares Held After
427,953
% of Holdings
2.7%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
24,880
Price
$6.96
Total Value
$173.26K
Shares Held After
493,557
% of Holdings
4.8%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
20,000
Price
$133.63
Total Value
$2.67M
Shares Held After
995,987
% of Holdings
2.0%
PALISADE BIO, INC. (PALI)
Baltera Robert Jr. — Director
Shares
20,000
Price
$1.99
Total Value
$39.80K
Shares Held After
436,904
% of Holdings
4.6%
AN2 Therapeutics, Inc. (ANTX)
Eizen Joshua M — Chief Operating Officer and Chief Legal Officer
Shares
5,945
Price
$4.17
Total Value
$24.80K
Shares Held After
206,554
% of Holdings
2.8%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,500
Price
$0.97
Total Value
$5.33K
Shares Held After
367,485
% of Holdings
1.5%
Seer, Inc. (SEER)
Nishar Dipchand — Director
Shares
10,660
Price
$2.18
Total Value
$23.27K
Shares Held After
59,044
% of Holdings
15.3%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
1,015
Price
$16.00
Total Value
$16.24K
Shares Held After
135,202
% of Holdings
0.7%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
300
Price
$73.69
Total Value
$22.11K
Shares Held After
492,012
% of Holdings
0.1%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
664
Price
$302.46
Total Value
$200.83K
Shares Held After
0
% of Holdings
100.0%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
830
Price
$30.31
Total Value
$25.16K
Shares Held After
129,855
% of Holdings
0.6%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
4,413
Price
$29.82
Total Value
$131.62K
Shares Held After
130,685
% of Holdings
3.3%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
22,757
Price
$28.60
Total Value
$650.90K
Shares Held After
135,098
% of Holdings
14.4%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
1,075
Price
$30.35
Total Value
$32.63K
Shares Held After
182,177
% of Holdings
0.6%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
4,306
Price
$29.80
Total Value
$128.30K
Shares Held After
183,252
% of Holdings
2.3%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
22,833
Price
$28.76
Total Value
$656.65K
Shares Held After
187,558
% of Holdings
10.9%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
77
Price
$39.99
Total Value
$3.08K
Shares Held After
208,198
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,399
Price
$39.53
Total Value
$55.30K
Shares Held After
208,275
% of Holdings
0.7%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
105
Price
$39.99
Total Value
$4.20K
Shares Held After
209,674
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Stout Jay S — Chief Technology Officer
Shares
1,906
Price
$39.53
Total Value
$75.34K
Shares Held After
209,779
% of Holdings
0.9%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
63
Price
$39.99
Total Value
$2.52K
Shares Held After
179,391
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Van Tuyl Christopher — Chief Legal Officer
Shares
1,143
Price
$39.53
Total Value
$45.18K
Shares Held After
179,454
% of Holdings
0.6%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
106
Price
$39.99
Total Value
$4.24K
Shares Held After
222,357
% of Holdings
0.0%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
1,930
Price
$39.53
Total Value
$76.29K
Shares Held After
222,463
% of Holdings
0.9%
Aktis Oncology, Inc. (AKTS)
Ron-Bigger Shulamit — Chief Operating Officer
Shares
4,200
Price
$28.75
Total Value
$120.74K
Shares Held After
0
% of Holdings
100.0%
Aktis Oncology, Inc. (AKTS)
Czibere Akos — Chief Medical Officer
Shares
4,371
Price
$28.71
Total Value
$125.48K
Shares Held After
0
% of Holdings
100.0%
Showing 1–50 of 202 transactions (page 1 of 5)